{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T05:44:20Z","timestamp":1789191860527,"version":"build-2803163510"},"reference-count":14,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:bold>Objective.<\/jats:bold>\n                    The obesity is associated with profound disturbances in appetite-regulating and metabolic hormones including ghrelin, leptin, adiponectin, resistin, and insulin. Bariatric arterial embolization (BEA) has recently emerged as a minimally invasive alternative to established bariatric procedures. However, comparative endocrine evidence remains limited. The aim of the study was to assess postoperative changes in key metabolic and appetite-regulating hormones following laparoscopic sleeve gastrectomy (LSG), laparoscopic gastric plication (LGP), and bariatric embolization of the gastric arteries (BEA).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods.<\/jats:bold>\n                    A total of 76 patients with obesity (BMI &gt;35 kg\/m\u00b2) were assigned to LSG (n=32), LGP (n=37), or BEA (n=7). Serum concentrations of total ghrelin, leptin, adiponectin, resistin, insulin, and HbA1c were measured preoperatively 3 and 6 months after intervention using standardized ELISA assays. Statistical significance was set at p&lt;0.05.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results.<\/jats:bold>\n                    All procedures resulted in significant improvements in hormonal and metabolic profiles within 6 months. Total ghrelin decreased by 55.6% after LGP, 69.7% after LSG, and 74.5% after BEA at 6 months (all p&lt;0.001). Leptin significantly declined, while adiponectin increased in all groups with the most pronounced early (3-month) rise after BEA (+36.1%, p=0.033). Resistin, insulin, and HbA1c progressively decreased across all interventions indicating improved insulin sensitivity. Overall, BEA demonstrated the strongest early hormonal response, whereas long-term (6-month) effects were comparable across procedures.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion.<\/jats:bold>\n                    Laparoscopic gastric plication, sleeve gastrectomy, and bariatric embolization provide substantial improvements in appetite-regulating and metabolic hormones in patients with obesity. BEA shows a particularly favorable early endocrine profile supporting its potential as a minimally invasive metabolic intervention.\n                  <\/jats:p>","DOI":"10.2478\/enr-2026-0006","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T07:06:04Z","timestamp":1774940764000},"page":"48-54","source":"Crossref","is-referenced-by-count":1,"title":["Modulation of appetite- and metabolism-regulating hormones after bariatric embolization, sleeve gastrectomy, and gastric plication"],"prefix":"10.2478","volume":"60","author":[{"given":"Andrii","family":"Prodan","sequence":"first","affiliation":[{"name":"Department of Surgery of the Postgraduate Faculty , I. Horbachevsky Ternopil National Medical University , Ternopil , Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ihor","family":"Dzubanovsky","sequence":"additional","affiliation":[{"name":"Department of Surgery of the Postgraduate Faculty , I. Horbachevsky Ternopil National Medical University , Ternopil , Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaroslav Ihorovych","family":"Havrysh","sequence":"additional","affiliation":[{"name":"Department of Surgery No. 1 , Danylo Halytsky Lviv National Medical University , Lviv , Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"key":"2026070616023707593_j_enr-2026-0006_ref_001","doi-asserted-by":"crossref","unstructured":"Ibrahim Abdalla MM. Ghrelin - physiological functions and regulation. Eur Endocrinol 11, 90\u201395, 2015.","DOI":"10.17925\/EE.2015.11.02.90"},{"key":"2026070616023707593_j_enr-2026-0006_ref_002","unstructured":"Beltowski J. Adiponectin and resistin--new hormones of white adipose tissue. Med Sci Monit 9, RA55\u201361, 2003."},{"key":"2026070616023707593_j_enr-2026-0006_ref_003","doi-asserted-by":"crossref","unstructured":"Fiorotti AM, Gomes ACA, Bortoli AM, Brito BD, Nunes KZ, Haraguchi FK, Bolsoni-Lopes A. Dynamic changes in adiponectin and resistin drive remission of cardiometabolic risk biomarkers in individuals with obesity following bariatric surgery. Pharmaceuticals 17, 215, 2024.","DOI":"10.3390\/ph17020215"},{"key":"2026070616023707593_j_enr-2026-0006_ref_004","doi-asserted-by":"crossref","unstructured":"Friedman JM. Leptin and the endocrine control of energy balance. Nat Metab 1, 754\u2013764, 2019.","DOI":"10.1038\/s42255-019-0095-y"},{"key":"2026070616023707593_j_enr-2026-0006_ref_005","doi-asserted-by":"crossref","unstructured":"Hedback N, Dichman ML, Hindso M, Dirksen C, Jorgensen NB, Bojsen-Moller KN, Kristiansen VB, Rehfeld JF, Hartmann B, Holst JJ, Svane MS, Madsbad S. Effect of ghrelin on glucose tolerance, gut hormones, appetite, and food intake after sleeve gastrectomy. Am J Physiol Endocrinol Metab 327, E396\u2013E410, 2024.","DOI":"10.1152\/ajpendo.00177.2024"},{"key":"2026070616023707593_j_enr-2026-0006_ref_006","doi-asserted-by":"crossref","unstructured":"Labounty TM, Gomez MJ, Achenbach S, Al-Mallah M, Berman DS, Budoff MJ, Cademartiri F, Callister TQ, Chang HJ, Cheng V, Chinnaiyan KM, Chow B, Cury R, Delago A, Dunning A, Feuchtner G, Hadamitzky M, Hausleiter J, Kaufmann P, Kim YJ, Leipsic J, Lin FY, Maffei E, Raff G, Shaw LJ, Villines TC, Min JK. Body mass index and the prevalence, severity, and risk of coronary artery disease: an international multicentre study of 13 874 patients. Eur Heart J Cardiovasc Imaging 14, 456\u2013463, 2013.","DOI":"10.1093\/ehjci\/jes179"},{"key":"2026070616023707593_j_enr-2026-0006_ref_007","unstructured":"Montegut L, Lopez-Otin C, Magnan C, Kroemer G. Old paradoxes and new opportunities for appetite control in obesity. Trends Endocrinol Metab 32, 264\u2013294, 2021."},{"key":"2026070616023707593_j_enr-2026-0006_ref_008","doi-asserted-by":"crossref","unstructured":"Nozari Y, Park C, Brietzke E, Iacobucci M, Gill H, McIntyre RS. Correlation between improved leptin signaling and cognitive function post bariatric surgery. J Affect Disord 326, 225\u2013231, 2023.","DOI":"10.1016\/j.jad.2023.01.100"},{"key":"2026070616023707593_j_enr-2026-0006_ref_009","doi-asserted-by":"crossref","unstructured":"Sangiorgi GM, Cereda A, Porchetta N, Benedetto D, Matteucci A, Bonanni M, Chiricolo G, De Lorenzo A. Endovascular bariatric surgery as novel minimally invasive technique for weight management in the morbidly obese: review of the literature. Nutrients 13, 2541, 2021.","DOI":"10.3390\/nu13082541"},{"key":"2026070616023707593_j_enr-2026-0006_ref_010","doi-asserted-by":"crossref","unstructured":"Sebunova N, Stsep\u0435\u0442\u043e\u0432\u0430 J, Kullisaar T, Suija K, Ratsep A, Junkin I, Soeorg H, Lember M, Sillakivi T, Mandar R. Changes in adipokine levels and metabolic profiles following bariatric surgery. BMC Endocr Disord 22, 33, 2022.","DOI":"10.1186\/s12902-022-00942-7"},{"key":"2026070616023707593_j_enr-2026-0006_ref_011","doi-asserted-by":"crossref","unstructured":"Sethi P, Thillai M, Nain PS, Ahuja A, Aulakh N, Khurana P. Role of hunger hormone \u201cghrelin\u201d in long-term weight loss following laparoscopic sleeve gastrectomy. Niger J Surg 24, 121\u2013124, 2018.","DOI":"10.4103\/njs.NJS_24_17"},{"key":"2026070616023707593_j_enr-2026-0006_ref_012","doi-asserted-by":"crossref","unstructured":"Skuratovskaia D, Vulf M, Chasovskikh N, Komar A, Kirienkova E, Shunkin E, Zatolokin P, Litvinova L. The links of ghrelin to incretins, insulin, glucagon, and leptin after bariatric surgery. Front Genet 12, 612501, 2021.","DOI":"10.3389\/fgene.2021.612501"},{"key":"2026070616023707593_j_enr-2026-0006_ref_013","doi-asserted-by":"crossref","unstructured":"Syed MI, Morar K, Shaikh A, Craig P, Khan O, Patel S, Khabiri H. Gastric artery embolization trial for the lessening of appetite nonsurgically (GET LEAN): six-month preliminary data. J Vasc Interv Radiol 27, 1502\u20131508. 2016.","DOI":"10.1016\/j.jvir.2016.07.010"},{"key":"2026070616023707593_j_enr-2026-0006_ref_014","doi-asserted-by":"crossref","unstructured":"Vaz M, Pereira SS, Monteiro MP. Metabolomic signatures after bariatric surgery: A systematic review. Rev Endocr Metab Disord 23, 503\u2013519, 2021.","DOI":"10.1007\/s11154-021-09695-5"}],"container-title":["Endocrine Regulations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/enr-2026-0006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T16:11:40Z","timestamp":1783354300000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/enr-2026-0006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,1]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3,24]]},"published-print":{"date-parts":[[2026,1,1]]}},"alternative-id":["10.2478\/enr-2026-0006"],"URL":"https:\/\/doi.org\/10.2478\/enr-2026-0006","relation":{},"ISSN":["1336-0329"],"issn-type":[{"value":"1336-0329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,1]]}}}